Literature DB >> 29537998

Tissue Engineering Auricular Cartilage Using Late Passage Human Auricular Chondrocytes.

Jaime L Bernstein, Benjamin P Cohen, Alexandra Lin, Alice Harper, Lawrence J Bonassar, Jason A Spector.   

Abstract

PURPOSE: The significant shortcomings associated with current autologous reconstructive options for auricular deformities have inspired great interest in a tissue engineering solution. A major obstacle in the engineering of human auricular cartilage is the availability of sufficient autologous human chondrocytes. A clinically obtainable amount of auricular cartilage tissue (ie, 1 g) only yields approximately 10 million cells, where 25 times this amount is needed for the fabrication of a full-scale pediatric ear. It is thought that repeated passaging of chondrocytes leads to dedifferentiation and loss of the chondrogenic potential. However, little to no data exist regarding the ideal number of times that human auricular chondrocytes (HAuCs) can be passaged in a manner that maximizes the cellular expansion while minimizing dedifferentiation.
METHODS: Human auricular chondrocytes were isolated from discarded otoplasty specimens. The HAuCs were then expanded, and cells from passages 3, 4, and 5 were encapsulated into discs 8 mm in diameter made from type I collagen hydrogels with a cell density of 25 million cells/mL. The constructs were implanted subcutaneously in the dorsa of nude mice and harvested after 1 and 3 months for analysis.
RESULTS: Constructs containing passages 3, 4, and 5 chondrocytes all maintained their original cylindrical geometry. After 3 months in vivo, the diameters of the P3, P4, and P5 discs were 69 ± 9%, 67 ± 10%, and 73 ± 15% of their initial diameter, respectively. Regardless of the passage number, all constructs developed a glossy white cartilaginous appearance, similar to native auricular cartilage. Histologic analysis demonstrated development of an organized perichondrium composed of collagen, a rich proteoglycan matrix, cellular lacunae, and a dense elastin fibrin network by Safranin-O and Verhoeff stain. Biochemical analysis confirmed similar amounts of proteoglycan and hydroxyproline content in late passage constructs when compared with native auricular cartilage.
CONCLUSIONS: These data indicate that late passage HAuCs (up to passage 5) form elastic cartilage that is histologically, biochemically, and biomechanically similar to native human elastic cartilage and have the potential to be used for auricular cartilage engineering.

Entities:  

Mesh:

Year:  2018        PMID: 29537998      PMCID: PMC5910223          DOI: 10.1097/SAP.0000000000001400

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  43 in total

1.  Auricular reconstruction for microtia: Part II. Surgical techniques.

Authors:  Robert L Walton; Elisabeth K Beahm
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

2.  Self-assembly of aligned tissue-engineered annulus fibrosus and intervertebral disc composite via collagen gel contraction.

Authors:  Robby D Bowles; Rebecca M Williams; Warren R Zipfel; Lawrence J Bonassar
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

3.  Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue.

Authors:  B O Enobakhare; D L Bader; D A Lee
Journal:  Anal Biochem       Date:  1996-12-01       Impact factor: 3.365

4.  Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro.

Authors:  M Jakob; O Démarteau; D Schäfer; B Hintermann; W Dick; M Heberer; I Martin
Journal:  J Cell Biochem       Date:  2001-03-26       Impact factor: 4.429

5.  Psychosocial outcome of patients after ear reconstruction: a retrospective study of 62 patients.

Authors:  Nigel Horlock; Esther Vögelin; Eileen T Bradbury; Adriaan O Grobbelaar; David T Gault
Journal:  Ann Plast Surg       Date:  2005-05       Impact factor: 1.539

6.  Psychosocial outcomes among microtia patients of different ages and genders before ear reconstruction.

Authors:  Datao Li; WenShin Chin; Jinfang Wu; Qun Zhang; Feng Xu; Zhicheng Xu; Ruhong Zhang
Journal:  Aesthetic Plast Surg       Date:  2010-04-16       Impact factor: 2.326

7.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

8.  Scaffold-free cartilage fabrication system using passaged porcine chondrocytes and basic fibroblast growth factor.

Authors:  Ri Long Jin; So Ra Park; Byung Hyune Choi; Byoung-Hyun Min
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

9.  Cell-engineered human elastic chondrocytes regenerate natural scaffold in vitro and neocartilage with neoperichondrium in the human body post-transplantation.

Authors:  Hiroko Yanaga; Keisuke Imai; Mika Koga; Katsu Yanaga
Journal:  Tissue Eng Part A       Date:  2012-07-03       Impact factor: 3.845

10.  Tissue engineering auricular reconstruction: in vitro and in vivo studies.

Authors:  Shyh-Jou Shieh; Shinichi Terada; Joseph P Vacanti
Journal:  Biomaterials       Date:  2004-04       Impact factor: 12.479

View more
  3 in total

Review 1.  Tissue engineering applications in otolaryngology-The state of translation.

Authors:  Weston L Niermeyer; Cole Rodman; Michael M Li; Tendy Chiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-19

2.  Human adult, pediatric and microtia auricular cartilage harbor fibronectin-adhering progenitor cells with regenerative ear reconstruction potential.

Authors:  Iris A Otto; Paulina Nuñez Bernal; Margot Rikkers; Mattie H P van Rijen; Anneloes Mensinga; Moshe Kon; Corstiaan C Breugem; Riccardo Levato; Jos Malda
Journal:  iScience       Date:  2022-08-18

Review 3.  Auricular reconstruction: where are we now? A critical literature review.

Authors:  Sarah Humphries; Anil Joshi; William Richard Webb; Rahul Kanegaonkar
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-02       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.